Ramana Uppoor

1.2k citations

26 papers · 531 indexed · h-index 12

Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 2
Statistics and Probability top 5%
- Statistical Methods in Clinical Trials 6
Pharmacology top 5%
Pediatrics, Perinatology and Child Health top 10%
- Pharmaceutical studies and practices 13
Analytical Chemistry top 10%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 5
Psychiatry and Mental health
- Schizophrenia research and treatment 4
- Attention Deficit Hyperactivity Disorder 2
Oncology
- Drug Transport and Resistance Mechanisms 2

Co-authors: Patrick Marroum Natalie D. Eddington Larry L. Augsburger Veneeta Tandon Yaning Wang Mehul U. Mehta Tiffany Farchione Minesh P. Mehta
Cited by: Pharmaceutical Science Statistics and Probability Pharmacology
Partner nations: United States Thailand India

In The Last Decade

Ramana Uppoor

24 papers receiving 503 citations

Peers

Countries citing papers authored by Ramana Uppoor

Since Specialization

Citations

This map shows the geographic impact of Ramana Uppoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramana Uppoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramana Uppoor more than expected).

Fields of papers citing papers by Ramana Uppoor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramana Uppoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramana Uppoor. The network helps show where Ramana Uppoor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ramana Uppoor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ramana Uppoor Line = papers co-authored together Ramana Uppoor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments Robert Hopefl,Yuqing Gong,Elizabeth Bielski,Venkateswaran C. Pillai,Bryan Newman,Bin Qin,Yan Wang,Miyoung Yoon,Qiangnan Zhang,Ethan Stier,Ramana Uppoor,Hao Zhu,Lei Zhang,Lanyan Fang	2025	1
2	FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose Srikanth C. Nallani,Zhihua Li,Jeffry Florian,Yun Xu,Sreedharan Sabarinath,Tanya Brescia‐Oddo,Rigoberto Roca,Ramana Uppoor,Mehul U. Mehta	2024	0
3	Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia Huixia Zhang,Jie Liu,Vishnu Sharma,Luning Zhuang,Pamela Horn,Ramana Uppoor,Minesh P. Mehta,Hao Zhu	2024	1
4	Use of Partial Area Under the Curve in Bioavailability or Bioequivalence Assessments: A Regulatory Perspective Lanyan Fang,Ramana Uppoor,Ming‐Jiang Xu,Satish Sharan,Hao Zhu,Nilufer Tampal,Bing Li,Lei Zhang,Robert Lionberger,Liang Zhao	2021	7
5	Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder Shamir N. Kalaria,Tiffany Farchione,Ramana Uppoor,Mehul Mehta,Yaning Wang,Hao Zhu	2021	10
6	The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues Mathangi Gopalakrishnan,Hao Zhu,Tiffany Farchione,Mitchell Mathis,Minesh P. Mehta,Ramana Uppoor,Islam R. Younis	2020	19
7	An Innovative Pharmacometric Approach for the Simultaneous Analysis of Frequency, Duration and Severity of Migraine Events Alejandro Pérez‐Pitarch,Gopichand Gottipati,Ramana Uppoor,Mehul Mehta,Sreedharan Sabarinath	2020	1
8	Application of Clinical Pharmacology Principles in Drug Development of Modified‐Release Products: Leveraging Exposure‐Response Information to Support Approval Bilal Abuasal,Salaheldin S. Hamed,Mariam A. Ahmed,Lana Al‐Mansour,Ramana Uppoor,Minesh P. Mehta	2020	2
9	Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration Mathangi Gopalakrishnan,Tiffany Farchione,Mitchell Mathis,Hao Zhu,Mehul Mehta,Ramana Uppoor,Islam R. Younis	2020	1
10	Pharmacometric Bridging Approach for U.S. Food and Drug Administration Approval and Identification of Topiramate Dosing Regimen for Pediatric Patients 2-9 Years of Age With Epilepsy Anshu Marathe,Chao Liu,Leonard P. Kapcala,Norman Hershkowitz,Angela Men,Ramana Uppoor,Mehul Mehta,Yaning Wang	2018	4
11	Exposure–response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults Liang Li,Yaning Wang,Ramana Uppoor,Mehul U. Mehta,Tiffany Farchione,Mitchell Mathis,Hao Zhu	2017	11
12	Impact of the US FDA “Biopharmaceutics Classification System” (BCS) Guidance on Global Drug Development Mehul U. Mehta,Ramana Uppoor,Dale P. Conner,Paul Seo,Jayabharathi Vaidyanathan,Donna A. Volpe,Ethan Stier,Dakshina Chilukuri,Angelica Dorantes,Tapash K. Ghosh,Haritha Mandula,Kimberly Raines,Pariban Dhanormchitphong,Janet Woodcock,Lawrence X. Yu	2017	25
13	Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations Ethan Stier,Barbara M. Davit,Parthapratim Chandaroy,Mei‐Ling Chen,Jeanne Fourie-Zirkelbach,André J. Jackson,Stephanie Kim,Robert Lionberger,Minesh P. Mehta,Ramana Uppoor,Yaning Wang,Lawrence X. Yu,Dale P. Conner	2012	19
14	Essential Pharmacokinetic Information for Drug Dosage Decisions: A Concise Visual Presentation in the Drug Label Divya Menon-Andersen,Binbing Yu,R Madabushi,Venkatesh Atul Bhattaram,Hao Wang,Ramana Uppoor,Minesh P. Mehta,Lawrence J. Lesko,Robert Temple,Norman Stockbridge,Thomas Laughren,Jogarao Gobburu	2011	25
15	Effect of Ethanol on Opioid Drug Permeability Through Caco-2 Cell Monolayers Donna A. Volpe,Ebenezer B. Asafu-Adjaye,Christopher D. Ellison,Suresh Doddapaneni,Ramana Uppoor,Mansoor A. Khan	2008	18
16	Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned William Rodriguez,Arzu Selen,Debbie Avant,Chandra S. Chaurasia,Terrie Crescenzi,Gerlie Gieser,Jennifer Di Giacinto,Shiew‐Mei Huang,Peter P. Lee,Lisa L. Mathis,Dianne Murphy,S B Murphy,Rosemary Roberts,Hari Cheryl Sachs,Sandra Orozco‐Suárez,Veneeta Tandon,Ramana Uppoor	2008	114
17	Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications Venkatesh Atul Bhattaram,Brian Booth,Roshni Ramchandani,B. Nhi Beasley,Yaning Wang,Veneeta Tandon,John Duan,Raman Baweja,Patrick Marroum,Ramana Uppoor,Nam Atiqur Rahman,Chandrahas Sahajwalla,J. Robert Powell,Mehul U. Mehta,Jogarao Gobburu	2005	95
18	Evaluation of “External” Predictability of an In Vitro–In Vivo Correlation for an Extended‐Release Formulation Containing Metoprolol Tartrate Houda Mahayni,Gurvinder Singh Rekhi,Ramana Uppoor,Patrick Marroum,Abubakar Siddique Mustafa Hussain,Larry L. Augsburger,Natalie D. Eddington	2000	28
19	In vitro metabolic interaction studies: Experience of the Food and Drug Administration Ruihua Yuan,T PARMELEE,John Dikran Balian,Ramana Uppoor,Faith Ajayi,Arthur L. Burnett,Lawrence Lesko,Patrick Marroum	1999	44
20	Development and Internal Validation of an In Vitro-in Vivo Correlation for a Hydrophilic Metoprolol Tartrate Extended Release Tablet Formulation Natalie D. Eddington,Patrick Marroum,Ramana Uppoor,Ajaz Hussain,Larry L. Augsburger	1998	62

About Ramana Uppoor

Ramana Uppoor is a scholar working on Statistics and Probability, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 26 papers that have together received 531 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (13 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Statistical Methods in Clinical Trials (6 papers), Pharmaceutical Economics and Policy (5 papers), Schizophrenia research and treatment (4 papers), Attention Deficit Hyperactivity Disorder (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (107 citations), Statistics and Probability (90 citations) and Pharmacology (89 citations). Ramana Uppoor has collaborated with scholars based in United States, Thailand and India. Frequent co-authors include Patrick Marroum, Natalie D. Eddington, Larry L. Augsburger, Veneeta Tandon, Yaning Wang, Mehul U. Mehta, Tiffany Farchione, Minesh P. Mehta, Mitchell Mathis and Hao Zhu.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact